There has been recent change in the nomenclature of nonalcoholic fatty liver disease (NAFLD) to Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD). Significant advances have also happened in the field of noninvasive testing (NITs) and therapy of MASLD in the last couple of years.
-
Your Cart $430.00
-
×
Pregnancy and Thyroid Disease In stock
1 × $20.00 -
×
FOGSI FOCUS on Recurrent Pregnancy Loss In stock
1 × $40.00 -
×
COVID-19 Comprehensive Review In stock
1 × $25.00 -
×
Cardiology Update 2019 (Official Publication of CSI) In stock
1 × $90.00 -
×
Recent Advances in Obstetrics & Gynecology Vol 2 In stock
1 × $40.00 -
×
CARDIOLOGY Update 2021 In stock
1 × $130.00 -
×
YEARBOOK of Obstetrics and Gynecology 2019 In stock
1 × $30.00 -
×
Recent Advances in Obstetrics and Gynecology In stock
1 × $55.00
Subtotal: $430.00
-
×
-
8
-
×
Pregnancy and Thyroid Disease
In stock
1 × $20.00 -
×
FOGSI FOCUS on Recurrent Pregnancy Loss
In stock
1 × $40.00 -
×
COVID-19 Comprehensive Review
In stock
1 × $25.00 -
×
Cardiology Update 2019 (Official Publication of CSI)
In stock
1 × $90.00 -
×
Recent Advances in Obstetrics & Gynecology Vol 2
In stock
1 × $40.00 -
×
CARDIOLOGY Update 2021
In stock
1 × $130.00 -
×
YEARBOOK of Obstetrics and Gynecology 2019
In stock
1 × $30.00 -
×
Recent Advances in Obstetrics and Gynecology
In stock
1 × $55.00
Subtotal: $430.00
-
×
Related products
